Topics
Glioblastoma | Treatment | Clinical trials | Circadian clock
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Circadian clock
Chan P, Nagai Y, Wu Q, Hovsepyan A, Mkhitaryan S, Wang J,
Karapetyan G, Kamenecka T, Solt LA, Cope J, Moats RA, Hirota T,
Rich JN, Kay SA.
Advancing
Clinical Response Against
Glioblastoma: Evaluating SHP1705 CRY2 Activator
Efficacy in Preclinical Models and
Safety in Phase I Trials.
bioRxiv [Preprint]. 2024
Sep 21:2024.09.17.613520. doi:
10.1101/2024.09.17.613520. PMID:
39345648. Interventional study. ˍ